No Data
No Data
RAMM Pharma Corp. Awaits Key Litigation Verdict
RAMM Pharma Corp. Announced Corporate Update; Looking At Legal Options Around Private Placement; Rose 28% on Friday
RAMM Pharma Corp. (RAMM.CN), a provider of cannabis-based pharmaceuticals, that rose near 28% on Friday, over the weekend announced its intention to complete a non-brokered private placement of up to
RAMM Pharma Corp. Announces Corporate Update.
TORONTO, Nov. 17, 2023 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the "Company" or "RAMM") (CSE: RAMM), announced its intention to complet
RAMM Pharma Seeking Advice After CSE Required Shareholder Approval For Private Placement
RAMM Pharma Corp. (RAMM.CN), a provider of cannabis-based pharmaceuticals, said overnight Wednesday that the CSE required the company to obtain shareholder approval for its previously announced $1 mil
RAMM Pharma Corp. Announces Clarification of Its Corporate Update of September 12th
TORONTO, Sept. 27, 2023 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the "Company" or "RAMM") (CSE:RAMM), announced its intention to complete a
RAMM Pharma Corp. Announces Corporate Update
TORONTO, Sept. 12, 2023 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the "Company" or "RAMM") (CSE: RAMM), announced its intention to comple